ICDcodes.org
FY2027

C22 — Malignant neoplasm of liver and intrahepatic bile ducts

Not billable

Is C22 billable?

No — C22 is a non-billable header code. C22 groups more specific codes and cannot be submitted on a claim. A valid ICD-10-CM code must be reported at the highest level of specificity available in its branch. Select one of the 8 billable codes beneath C22.

C22 at a glance

CodeC22
DescriptionMalignant neoplasm of liver and intrahepatic bile ducts
BillableNo — header code
Code setICD-10-CM FY2027
Valid for encountersOctober 1, 2026 – September 30, 2027

Excludes1 — never code together

The conditions below can never be reported together with C22 on the same claim. An Excludes1 note means the two conditions cannot occur in the same patient, so reporting both is a coding error.

  • malignant neoplasm of biliary tract NOS (C24.9)
  • secondary malignant neoplasm of liver and intrahepatic bile duct (C78.7)

Use additional code

Report an additional code alongside C22 to fully describe the condition. C22 is sequenced first.

Excludes1 — never code together — inherited from C15-C26

The conditions below can never be reported together with C22 on the same claim. An Excludes1 note means the two conditions cannot occur in the same patient, so reporting both is a coding error.

  • Kaposi's sarcoma of gastrointestinal sites (C46.4)

Excludes2 — not included here — inherited from C15-C26

The conditions below are not part of C22, but a patient may have both at the same time. When documentation supports it, C22 and the excluded code may both be reported.

  • gastrointestinal stromal tumors (C49.A-)

What codes fall under C22? (8)

How long has C22 existed?

C22 has been in ICD-10-CM since at least FY2016, the earliest fiscal year on record here.

Derived from the official order files for FY2016–FY2026. FY2017 and FY2020 publish no order file, so those years are not covered.